Financials OrbusNeich Medical Group Holdings Limited

Equities

6929

KYG6773B1005

Medical Equipment, Supplies & Distribution

Market Closed - Hong Kong S.E. 04:08:20 2024-04-26 am EDT 5-day change 1st Jan Change
3.83 HKD +4.08% Intraday chart for OrbusNeich Medical Group Holdings Limited +6.09% -45.67%

Valuation

Fiscal Period: December 2022 2023 2024 2025 2026
Capitalization 1 6,433 5,305 2,935 - -
Enterprise Value (EV) 1 4,868 3,519 1,021 604 208.3
P/E ratio 43.9 x 16.5 x 9.01 x 7.54 x 6.89 x
Yield - 1.44% 2.54% 2.85% 4.46%
Capitalization / Revenue 6.77 x 4.79 x 2.3 x 1.98 x 1.82 x
EV / Revenue 5.12 x 3.18 x 0.8 x 0.41 x 0.13 x
EV / EBITDA 28.4 x 11.1 x 2.69 x 1.38 x 0.49 x
EV / FCF 34.5 x - 3.02 x 1.65 x 0.64 x
FCF Yield 2.9% - 33.1% 60.8% 155%
Price to Book - - 0.98 x 0.86 x 0.73 x
Nbr of stocks (in thousands) 827,770 827,968 827,968 - -
Reference price 2 7.772 6.408 3.545 3.545 3.545
Announcement Date 3/8/23 3/7/24 - - -
1CNY in Million2CNY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2021 2022 2023 2024 2025 2026
Net sales 1 - 950.9 1,107 1,277 1,483 1,616
EBITDA 1 - 171.6 317.7 380.2 436.3 428.1
EBIT 1 - 146.5 287.5 348.2 403.5 398.4
Operating Margin - 15.4% 25.96% 27.27% 27.21% 24.66%
Earnings before Tax (EBT) 1 - 151.4 357.2 427.9 510.6 626
Net income 1 -31.01 128.5 324.4 335.8 385.9 419.9
Net margin - 13.51% 29.29% 26.29% 26.03% 25.99%
EPS 2 -0.0105 0.1772 0.3894 0.3933 0.4700 0.5145
Free Cash Flow 1 - 141.2 - 338.2 367 323.8
FCF margin - 14.85% - 26.48% 24.75% 20.04%
FCF Conversion (EBITDA) - 82.28% - 88.95% 84.11% 75.64%
FCF Conversion (Net income) - 109.86% - 100.73% 95.1% 77.12%
Dividend per Share 2 - - 0.0921 0.0900 0.1010 0.1580
Announcement Date 12/12/22 3/8/23 3/7/24 - - -
1CNY in Million2CNY
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2022 S2 2023 S1 2023 S2
Net sales 1 472.7 593.6 521.5
EBITDA - - -
EBIT 1 70.61 175.8 113.9
Operating Margin 14.94% 29.62% 21.85%
Earnings before Tax (EBT) 1 84.15 204.4 155.5
Net income 1 72.69 183.6 143.2
Net margin 15.38% 30.93% 27.45%
EPS - - -
Dividend per Share - - -
Announcement Date 3/8/23 8/17/23 3/7/24
1CNY in Million
Estimates

Balance Sheet Analysis

Fiscal Period: December 2021 2022 2023 2024 2025 2026
Net Debt 1 - - - - - -
Net Cash position 1 - 1,565 1,786 1,914 2,331 2,727
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 - 141 - 338 367 324
ROE (net income / shareholders' equity) - 7.31% 13.4% 11.9% 12.2% 11.7%
ROA (Net income/ Total Assets) - 5.97% 12.1% 11% 11.3% 10.9%
Assets 1 - 2,153 2,675 3,066 3,408 3,870
Book Value Per Share 2 - - - 3.620 4.110 4.860
Cash Flow per Share 2 - - - 0.4300 0.4300 -
Capex 1 - 19.9 - 102 96.9 27
Capex / Sales - 2.1% - 8% 6.53% 1.67%
Announcement Date 12/12/22 3/8/23 3/7/24 - - -
1CNY in Million2CNY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
3.545 CNY
Average target price
6.393 CNY
Spread / Average Target
+80.33%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. 6929 Stock
  4. Financials OrbusNeich Medical Group Holdings Limited